Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsBlair, J C
Miraki Moud, F
Clayton, P E
Savage, M O
MetadataShow full item record
CitationClin. Endocrinol. (Oxf) 2004, 60(2):163-8; discussion 161-2
AbstractOBJECTIVE: Abnormalities in the GH-IGF-I axis, consistent with GH insensitivity (GHI), have been reported in some patients with idiopathic short stature (ISS). The standard IGF-I generation test (IGFGT) has not demonstrated mild GHI in subjects with ISS. The aim of this study was to investigate the GH-IGF-I axis in ISS by performing standard and novel low-dose IGFGTs together with determination of spontaneous GH secretion. PATIENTS AND METHODS: Twenty-one (17 male) prepubertal children with ISS, mean age 8.3 years (4.5-12.2), mean height -3.48 SD (-5.40 to -1.79), mean peak GH to provocation with glucagon/clonidine 32.3 mU/l (14.1-66.0) were studied. Serum IGF-I and IGFBP-3 levels were measured during standard (GH 0.033 mg/kg/day x 4) and low (GH 0.011 mg/kg/day x 4) dose IGFGTs at 0, 12, 36 and 84 h. The low-dose IGFGT was performed in seven naive GH-deficient patients (4 male), mean age 8.5 years (range 4.1-11.1). Determination of spontaneous 24-h GH secretion was performed in the 21 ISS patients. RESULTS: Basal IGF-I and IGFBP-3 standard deviation scores (SDS) in ISS patients were -1.39 (-2.4-1.16) and -0.45 (-1.13-0.38), respectively, IGF-I being lower than IGFBP-3 (P < 0.0001). IGF-I increased in the standard IGFGT at 12 h (P < 0.005), 36 h (P < 0.001) and 84 h (P < 0.001); maximal increment 1.54 (-0.32-3.48), and in the low-dose test at 12 h (P < 0.005), 36 h (P < 0.001) and 84 h (P < 0.005); maximal increment 0.53 (0.08 to -1.23). IGFBP-3 SDS increased in the standard IGFGT at 36 h (P < 0.01) and 84 h (P < 0.001); maximal increment 0.72 (-0.44-1.96), and in the low-dose test at 84 h (P < 0.005); maximal increment 0.33 (-0.08-0.87). Five/19 patients with an IGF-I response > 2 x coefficient of variation (CV) of assay in the standard test failed to respond in the low-dose test, suggestive of mild GHI. In GH-deficient patients, IGF-I increased at each time point (P < 0.05) and IGFBP-3 at 36 h (P < 0.05). Mean GH secretion, expressed in SDS, compared with 66 normal stature controls was: basal GH -0.48 (-0.84-0.93), height of GH peaks compared with zero -0.36 (-1.26-1.51) (both P < 0.05), total GH secretion -0.76 (-1.22-0.42), total GH secretion above baseline -0.67 (-1.21-0.94) (both P < 0.01). CONCLUSIONS: In children with ISS, basal IGF-I and IGFBP-3 SDS values were below the mean, IGF-I showing a greater response in both IGFGTs. In the standard IGFGT, the IGF-I increase at 36 h was equal to that at 84 h. The low-dose IGFGT, in combination with the standard test, may identify patients with mild GHI.
- Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
- Authors: Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO
- Issue date: 1998 Jun
- Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
- Authors: Cianfarani S, Tondinelli T, Spadoni GL, Scirè G, Boemi S, Boscherini B
- Issue date: 2002 Aug
- Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
- Authors: Rogol AD, Blethen SL, Sy JP, Veldhuis JD
- Issue date: 2003 Feb
- Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
- Authors: de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL
- Issue date: 1994 Nov
- Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
- Authors: Maghnie M, Barreca A, Ventura M, Tinelli C, Ponzani P, De Giacomo C, Maggiore G, Severi F
- Issue date: 1998 Jun
Showing items related by title, author, creator and subject.
Decrease in adiponectin levels correlates to growth response in growth hormone-treated childrenAndersson, B; Carlsson, L M S; Carlsson, B; Albertsson-Wikland, K; Bjarnason, R; Department of Pediatrics, Goteborg Pediatric Growth Research Center, The Institute of Clinical Sciences, Göteborg, Sweden. (Karger, 2009-04-01)BACKGROUND/AIMS: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. METHODS: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 +/- 2.38 years. Adiponectin levels in serum were measured using an ELISA. Results: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 +/- 5.71 to 13.1 +/- 5.22 (p < 0.0001), 10.3 +/- 4.82 (p < 0.0001) and 12.5 +/- 5.34 microg/ml (p < 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = -0.38, p < 0.0001 and r = -0.47, p < 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. CONCLUSIONS: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.
Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D cultureIngthorsson, Saevar; Sigurdsson, Valgardur; Fridriksdottir, Agla Jr; Jonasson, Jon G; Kjartansson, Jens; Magnusson, Magnus K; Gudjonsson, Thorarinn; Stem cell research unit, Department of anatomy, Faculty of medicine, University of Iceland and Department of laboratory hematology, Landspitali, university hospital, (Vatnsmýrarvegur 16), Reykjavík, (101), Iceland. firstname.lastname@example.org. (BioMed Central Ltd, 2010-07)ABSTRACT: BACKGROUND: Epithelial-stromal interaction provides regulatory signals that maintain correct histoarchitecture and homeostasis in the normal breast and facilitates tumor progression in breast cancer. However, research on the regulatory role of the endothelial component in the normal and malignant breast gland has largely been neglected. The aim of the study was to investigate the effects of endothelial cells on growth and differentiation of human breast epithelial cells in a three-dimensional (3D) co-culture assay. METHODS: Breast luminal and myoepithelial cells and endothelial cells were isolated from reduction mammoplasties. Primary cells and established normal and malignant breast cell lines were embedded in reconstituted basement membrane in direct co-culture with endothelial cells and by separation of Transwell filters. Morphogenic and phenotypic profiles of co-cultures was evaluated by phase contrast microscopy, immunostaining and confocal microscopy. RESULTS: In co-culture, endothelial cells stimulate proliferation of both luminal- and myoepithelial cells. Furthermore, endothelial cells induce a subpopulation of luminal epithelial cells to form large acini/ducts with a large and clear lumen. Endothelial cells also stimulate growth and cloning efficiency of normal and malignant breast epithelial cell lines. Transwell and gradient co-culture studies show that endothelial derived effects are mediated - at least partially - by soluble factors. CONCLUSION: Breast endothelial cells - beside their role in transporting nutrients and oxygen to tissues - are vital component of the epithelial microenvironment in the breast and provide proliferative signals to the normal and malignant breast epithelium. These growth promoting effects of endothelial cells should be taken into consideration in breast cancer biology.
Exclusive breastfeeding for 4 versus 6 months and growth in early childhood.Jonsdottir, Olof H; Kleinman, Ronald E; Wells, Jonathan C; Fewtrell, Mary S; Hibberd, Patricia L; Gunnlaugsson, Geir; Thorsdottir, Inga; Landspitali, Unit Nutr Res, Reykjavik, Iceland, Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Reykjavik, Iceland, Harvard Univ, Massachusetts Gen Hosp Children, Sch Med, Dept Pediat, Boston, MA USA, UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England, Harvard Univ, Sch Med, Massachusetts Gen Hosp Children, Div Global Hlth, Boston, MA USA, Directorate Hlth, Reykjavik, Iceland, Reykjavik Univ, Reykjavik, Iceland (Wiley-Blackwell, 2014-01)Exclusive breastfeeding for the first 4 or 6 months of life does not seem to affect the risk of being overweight or the prevalence of those who were overweight in early childhood.